Orphazyme investors snatched up profits before FDA failure
Related articles
Orphazyme to get rid of two thirds of employees
For subscribers
A part of Watch Media
For subscribers
Stay ahead of development by receiving our newsletter on the latest sector knowledge.
Newsletter termsLead Regulatory Professional – Combination Products
Experienced Statistician
Senior Manager, QA GCP
Scientist for GMP material qualification and coordination
Laboratory Technician
Drug Product Scientist
Skilled Process Specialist for managing logistic and production processes in SAP
(Senior) Drug Product Specialist
Senior Director R&D Project Management Office (PMO)
Senior Account Manager, Merck Life Science
Environmental Monitoring Professional
Senior Data Manager
Team Manager Purification
Senior Laboratory Technician/Laborant/Bioanalytiker – Biophysical Protein Characterization
Global Pharmaceutical Account Manager, Brenntag Pharma
ESG Officer
International Marketing Manager/Director
Governmental Public Affairs & Communications Head
Investor Relations Manager
Global Medical Affairs Manager – Medical Communication and Strategy
Global Medical Affairs Manager – Medical Excellence and Field Data
Associate Director for Laboratory Automation Development
Production chemist
Principal Medical Writer
Razor-sharp leader for Environmental Monitoring & Facility Support
Associate Director/Director of Toxicology
Quality Engineer for Production
(Senior) Analytical Scientist
Country Sales Manager DK/NO
Director of in vivo pharmacology
Experienced Biostatistician
Toxicologist, Non-clinical Development
Principal Research Scientist within Biophysical characterisation and pre-formulation